allogenic NK cell therapy (The Second Hospital of Shandong University)

N/A

Report date: 2025/06/11 10:46:48

Base Information

Drug Nameallogenic NK cell therapy (The Second Hospital of Shandong University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Second Hospital Of Shandong University
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Hospital Of Shandong University
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A